Efficacy of iptacopan monotherapy for suboptimal response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Aim. To evaluate the hematological response within 4 weeks of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria and suboptimal response to long-term eculizumab therapy. Materials and methods. The analysis included 8 patients, median age 32 years, with persistent anemia on...

Full description

Saved in:
Bibliographic Details
Main Authors: Olesya U. Klimova, Irina K. Golubovskaya, Yuriy N. Kuznetsov, Maria V. Marchenko, Alexander D. Kulagin
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2025-01-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/646296/175203
Tags: Add Tag
No Tags, Be the first to tag this record!